SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Break Above 50 Day Moving Average – Here’s Why

SPDR S&P Biotech ETF (NYSEARCA:XBI)’s share price passed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $155.11 and traded as high as $157.92. SPDR S&P Biotech ETF shares last traded at $156.90, with a volume of 8,885,297 shares.

SPDR S&P Biotech ETF Price Performance

The company has a 50-day moving average of $154.82 and a two-hundred day moving average of $142.69. The company has a market capitalization of $10.55 billion, a PE ratio of 11.47 and a beta of 0.87.

Institutional Investors Weigh In On SPDR S&P Biotech ETF

A number of institutional investors have recently bought and sold shares of the business. Group One Trading LLC purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at $34,617,000. GW&K Investment Management LLC boosted its stake in shares of SPDR S&P Biotech ETF by 696.6% during the third quarter. GW&K Investment Management LLC now owns 4,947 shares of the exchange traded fund’s stock valued at $780,000 after purchasing an additional 4,326 shares during the period. URS Advisory LLC grew its stake in SPDR S&P Biotech ETF by 9.1% in the 3rd quarter. URS Advisory LLC now owns 31,324 shares of the exchange traded fund’s stock worth $4,939,000 after acquiring an additional 2,607 shares in the last quarter. Private Advisor Group LLC increased its holdings in SPDR S&P Biotech ETF by 34.7% during the 3rd quarter. Private Advisor Group LLC now owns 51,110 shares of the exchange traded fund’s stock worth $8,059,000 after purchasing an additional 13,172 shares during the period. Finally, Tyche Wealth Partners LLC increased its stake in shares of SPDR S&P Biotech ETF by 8.4% during the third quarter. Tyche Wealth Partners LLC now owns 1,619 shares of the exchange traded fund’s stock valued at $255,000 after buying an additional 125 shares during the period.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.